Facebook
Instagram
Twitter
Youtube
Latest Testing Methods Result in Suspension of Two Russian Powerlifters for Anti-Doping
New testing methods have resulted in two Russian Powerlifters receiving two year suspensions for Anti-Doping Rule Violations. 08 Sep 2012
London 2012 unveil Anti-Doping Laboratory.
"These findings prove the efficiency and effectiveness of the IPC Anti-Doping programme in place for the Games."
New testing methods introduced at the Drug Control Centre, the King's College Laboratory, Harlow, prior to London 2012 have resulted in two Russian powerlifters each receiving two year suspensions for Anti-Doping Rule Violations involving Human Growth Hormone the International Paralympic Committee (IPC) has announced.
The athletes - Nikolay Marfin and Vadim Rakitin - each returned adverse analytical findings in blood samples taken from out of competition tests conducted on 23 August and 25 August in London, before the start of the Paralympic Games.
According to the Drug Control Centre, the blood samples contained Human Growth Hormone, which is classified by the World Anti-Doping Code 2012 Prohibited List as S2. Growth Hormone, and is therefore prohibited under the IPC Anti-Doping Code.
Both athletes were notified of their respective Anti-Doping Rule Violation on 4 September, the same day the laboratory results were received by the IPC, and were immediately suspended.
Rakitin had competed in the men's -90kg class at the Paralympic Games on 4 September and Marfin was due to compete on 6 September in the men's +100kg class, but was prohibited from competing.
In accordance with the IPC Anti-Doping Code, both Marfin and Rakitin will each serve two year suspensions for the offences. Upon being notified of the adverse analytical findings, both athletes admitted to injecting Human Growth Hormone. Each of their suspensions will start from 23 August, the date when the first blood samples were collected. All competition results obtained from 23 August and onwards will be disqualified. In addition, a financial sanction of ?1,500 was also imposed on each athlete.
Toni Pascual, Chairperson of the IPC Anti-Doping Committee, said: "This case is a world first as some of the latest testing methods were used which were only introduced prior to London 2012. These new methods are able to detect misuse of Human Growth Hormone over a span of weeks compared to previous methods used which only detected use over a shorter time period."
"These findings prove the efficiency and effectiveness of the IPC Anti-Doping programme in place for the Games."
